Global Nucleic Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18699090 | Publishing Date : 06-Jul-2021 | No. of pages : 117
Detailed TOC of Global Nucleic Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Nucleic Vaccine Market Overview1.1 Nucleic Vaccine Product Overview
1.2 Nucleic Vaccine Market Segment by Type
1.2.1 Preventive Nucleic Vaccine
1.2.2 Therapeutic Nucleic Vaccine
1.3 Global Nucleic Vaccine Market Size by Type
1.3.1 Global Nucleic Vaccine Market Size Overview by Type (2016-2027)
1.3.2 Global Nucleic Vaccine Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Nucleic Vaccine Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Nucleic Vaccine Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Nucleic Vaccine Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Nucleic Vaccine Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Nucleic Vaccine Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Nucleic Vaccine Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Nucleic Vaccine Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nucleic Vaccine Sales Breakdown by Type (2016-2021)
1.4.2 Europe Nucleic Vaccine Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Nucleic Vaccine Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Nucleic Vaccine Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Nucleic Vaccine Sales Breakdown by Type (2016-2021)
2 Global Nucleic Vaccine Market Competition by Company
2.1 Global Top Players by Nucleic Vaccine Sales (2016-2021)
2.2 Global Top Players by Nucleic Vaccine Revenue (2016-2021)
2.3 Global Top Players Nucleic Vaccine Price (2016-2021)
2.4 Global Top Manufacturers Nucleic Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nucleic Vaccine Market Competitive Situation and Trends
2.5.1 Nucleic Vaccine Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Nucleic Vaccine Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Vaccine as of 2020)
2.7 Date of Key Manufacturers Enter into Nucleic Vaccine Market
2.8 Key Manufacturers Nucleic Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nucleic Vaccine Status and Outlook by Region
3.1 Global Nucleic Vaccine Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Nucleic Vaccine Historic Market Size by Region
3.2.1 Global Nucleic Vaccine Sales in Volume by Region (2016-2021)
3.2.2 Global Nucleic Vaccine Sales in Value by Region (2016-2021)
3.2.3 Global Nucleic Vaccine Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Nucleic Vaccine Forecasted Market Size by Region
3.3.1 Global Nucleic Vaccine Sales in Volume by Region (2022-2027)
3.3.2 Global Nucleic Vaccine Sales in Value by Region (2022-2027)
3.3.3 Global Nucleic Vaccine Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Nucleic Vaccine by Application
4.1 Nucleic Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Nucleic Vaccine Market Size by Application
4.2.1 Global Nucleic Vaccine Market Size Overview by Application (2016-2027)
4.2.2 Global Nucleic Vaccine Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Nucleic Vaccine Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Nucleic Vaccine Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Nucleic Vaccine Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Nucleic Vaccine Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Nucleic Vaccine Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Nucleic Vaccine Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Nucleic Vaccine Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nucleic Vaccine Sales Breakdown by Application (2016-2021)
4.3.2 Europe Nucleic Vaccine Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Nucleic Vaccine Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Nucleic Vaccine Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Nucleic Vaccine Sales Breakdown by Application (2016-2021)
5 North America Nucleic Vaccine by Country
5.1 North America Nucleic Vaccine Historic Market Size by Country
5.1.1 North America Nucleic Vaccine Sales in Volume by Country (2016-2021)
5.1.2 North America Nucleic Vaccine Sales in Value by Country (2016-2021)
5.2 North America Nucleic Vaccine Forecasted Market Size by Country
5.2.1 North America Nucleic Vaccine Sales in Volume by Country (2022-2027)
5.2.2 North America Nucleic Vaccine Sales in Value by Country (2022-2027)
6 Europe Nucleic Vaccine by Country
6.1 Europe Nucleic Vaccine Historic Market Size by Country
6.1.1 Europe Nucleic Vaccine Sales in Volume by Country (2016-2021)
6.1.2 Europe Nucleic Vaccine Sales in Value by Country (2016-2021)
6.2 Europe Nucleic Vaccine Forecasted Market Size by Country
6.2.1 Europe Nucleic Vaccine Sales in Volume by Country (2022-2027)
6.2.2 Europe Nucleic Vaccine Sales in Value by Country (2022-2027)
7 Asia-Pacific Nucleic Vaccine by Region
7.1 Asia-Pacific Nucleic Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Nucleic Vaccine Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Nucleic Vaccine Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Nucleic Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Nucleic Vaccine Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Nucleic Vaccine Sales in Value by Region (2022-2027)
8 Latin America Nucleic Vaccine by Country
8.1 Latin America Nucleic Vaccine Historic Market Size by Country
8.1.1 Latin America Nucleic Vaccine Sales in Volume by Country (2016-2021)
8.1.2 Latin America Nucleic Vaccine Sales in Value by Country (2016-2021)
8.2 Latin America Nucleic Vaccine Forecasted Market Size by Country
8.2.1 Latin America Nucleic Vaccine Sales in Volume by Country (2022-2027)
8.2.2 Latin America Nucleic Vaccine Sales in Value by Country (2022-2027)
9 Middle East and Africa Nucleic Vaccine by Country
9.1 Middle East and Africa Nucleic Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Nucleic Vaccine Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Nucleic Vaccine Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Nucleic Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Nucleic Vaccine Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Nucleic Vaccine Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Nucleic Vaccine Business
10.1 Moderna
10.1.1 Moderna Corporation Information
10.1.2 Moderna Introduction and Business Overview
10.1.3 Moderna Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Moderna Nucleic Vaccine Products Offered
10.1.5 Moderna Recent Development
10.2 CureVac
10.2.1 CureVac Corporation Information
10.2.2 CureVac Introduction and Business Overview
10.2.3 CureVac Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Moderna Nucleic Vaccine Products Offered
10.2.5 CureVac Recent Development
10.3 Inovio
10.3.1 Inovio Corporation Information
10.3.2 Inovio Introduction and Business Overview
10.3.3 Inovio Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Inovio Nucleic Vaccine Products Offered
10.3.5 Inovio Recent Development
10.4 Sanofi
10.4.1 Sanofi Corporation Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Sanofi Nucleic Vaccine Products Offered
10.4.5 Sanofi Recent Development
10.5 GSK
10.5.1 GSK Corporation Information
10.5.2 GSK Introduction and Business Overview
10.5.3 GSK Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.5.4 GSK Nucleic Vaccine Products Offered
10.5.5 GSK Recent Development
10.6 CNBG
10.6.1 CNBG Corporation Information
10.6.2 CNBG Introduction and Business Overview
10.6.3 CNBG Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.6.4 CNBG Nucleic Vaccine Products Offered
10.6.5 CNBG Recent Development
10.7 Hualan Bio
10.7.1 Hualan Bio Corporation Information
10.7.2 Hualan Bio Introduction and Business Overview
10.7.3 Hualan Bio Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Hualan Bio Nucleic Vaccine Products Offered
10.7.5 Hualan Bio Recent Development
10.8 Zhifei Shengwu
10.8.1 Zhifei Shengwu Corporation Information
10.8.2 Zhifei Shengwu Introduction and Business Overview
10.8.3 Zhifei Shengwu Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Zhifei Shengwu Nucleic Vaccine Products Offered
10.8.5 Zhifei Shengwu Recent Development
10.9 Liaoning Chengda
10.9.1 Liaoning Chengda Corporation Information
10.9.2 Liaoning Chengda Introduction and Business Overview
10.9.3 Liaoning Chengda Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Liaoning Chengda Nucleic Vaccine Products Offered
10.9.5 Liaoning Chengda Recent Development
10.10 BioKangtai
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Nucleic Vaccine Product Category, Application and Specification
10.10.3 BioKangtai Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 BioKangtai Recent Development
10.11 CanSinoBIO
10.11.1 CanSinoBIO Corporation Information
10.11.2 CanSinoBIO Introduction and Business Overview
10.11.3 CanSinoBIO Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.11.4 CanSinoBIO Nucleic Vaccine Products Offered
10.11.5 CanSinoBIO Recent Development
10.12 Walvax Biotechnology
10.12.1 Walvax Biotechnology Corporation Information
10.12.2 Walvax Biotechnology Introduction and Business Overview
10.12.3 Walvax Biotechnology Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Walvax Biotechnology Nucleic Vaccine Products Offered
10.12.5 Walvax Biotechnology Recent Development
10.13 Fosun Pharma
10.13.1 Fosun Pharma Corporation Information
10.13.2 Fosun Pharma Introduction and Business Overview
10.13.3 Fosun Pharma Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Fosun Pharma Nucleic Vaccine Products Offered
10.13.5 Fosun Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nucleic Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nucleic Vaccine Industrial Chain Analysis
11.4 Nucleic Vaccine Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nucleic Vaccine Distributors
12.3 Nucleic Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Nucleic Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of Preventive Nucleic Vaccine
Table 2. Major Company of Therapeutic Nucleic Vaccine
Table 3. Global Nucleic Vaccine Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 4. Global Nucleic Vaccine Sales by Type (2016-2021) & (K Units)
Table 5. Global Nucleic Vaccine Sales Market Share in Volume by Type (2016-2021)
Table 6. Global Nucleic Vaccine Sales by Type (2016-2021) & (US& Million)
Table 7. Global Nucleic Vaccine Market Share in Value by Type (2016-2021)
Table 8. Global Nucleic Vaccine Price by Type (2016-2021) & (US$/Unit)
Table 9. Global Nucleic Vaccine Sales by Type (2022-2027) & (K Units)
Table 10. Global Nucleic Vaccine Sales Market Share in Volume by Type (2022-2027)
Table 11. Global Nucleic Vaccine Sales by Type (2022-2027) & (US$ Million)
Table 12. Global Nucleic Vaccine Sales Market Share in Value by Type (2022-2027)
Table 13. Global Nucleic Vaccine Price by Type (2022-2027) & (US$/Unit)
Table 14. North America Nucleic Vaccine Sales by Type (2016-2021) & (K Units)
Table 15. North America Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 16. Europe Nucleic Vaccine Sales (K Units) by Type (2016-2021)
Table 17. Europe Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 18. Asia-Pacific Nucleic Vaccine Sales (K Units) by Type (2016-2021)
Table 19. Asia-Pacific Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 20. Latin America Nucleic Vaccine Sales (K Units) by Type (2016-2021)
Table 21. Latin America Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 22. Middle East and Africa Nucleic Vaccine Sales (K Units) by Type (2016-2021)
Table 23. Middle East and Africa Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 24. Global Nucleic Vaccine Sales by Company (2016-2021) & (K Units)
Table 25. Global Nucleic Vaccine Sales Share by Company (2016-2021)
Table 26. Global Nucleic Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 27. Global Nucleic Vaccine Revenue Share by Company (2016-2021)
Table 28. Global Market Nucleic Vaccine Price by Company (2016-2021) & (US$/Unit)
Table 29. Global Nucleic Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Nucleic Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Vaccine as of 2020
Table 32. Date of Key Manufacturers Enter into Nucleic Vaccine Market
Table 33. Key Manufacturers Nucleic Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Nucleic Vaccine Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 36. Global Nucleic Vaccine Sales by Region (2016-2021) & (K Units)
Table 37. Global Nucleic Vaccine Sales Market Share in Volume by Region (2016-2021)
Table 38. Global Nucleic Vaccine Sales by Region (2016-2021) & (US$ Million)
Table 39. Global Nucleic Vaccine Sales Market Share in Value by Region (2016-2021)
Table 40. Global Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 41. Global Nucleic Vaccine Sales by Region (2022-2027) & (K Units)
Table 42. Global Nucleic Vaccine Sales Market Share in Volume by Region (2022-2027)
Table 43. Global Nucleic Vaccine Sales by Region (2022-2027) & (US$ Million)
Table 44. Global Nucleic Vaccine Sales Market Share in Value by Region (2022-2027)
Table 45. Global Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027)
Table 46. Global Nucleic Vaccine Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 47. Global Nucleic Vaccine Sales by Application (2016-2021) & (K Units)
Table 48. Global Nucleic Vaccine Sales Market Share in Volume by Application (2016-2021)
Table 49. Global Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 50. Global Nucleic Vaccine Sales Market Share in Value by Application (2016-2021)
Table 51. Global Nucleic Vaccine Price by Application (2016-2021) & (US$/Unit)
Table 52. Global Nucleic Vaccine Sales by Application (2022-2027) & (K Units)
Table 53. Global Nucleic Vaccine Sales Market Share in Volume by Application (2022-2027)
Table 54. Global Nucleic Vaccine Sales by Application (2022-2027) & (US$ Million)
Table 55. Global Nucleic Vaccine Sales Market Share in Value by Application (2022-2027)
Table 56. Global Nucleic Vaccine Price by Application (2022-2027) & (US$/Unit)
Table 57. North America Nucleic Vaccine Sales by Application (2016-2021) (K Units)
Table 58. North America Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 59. North America Nucleic Vaccine Sales Market Share in Value by Application in 2020
Table 60. Europe Nucleic Vaccine Sales by Application (2016-2021) (K Units)
Table 61. Europe Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 62. Europe Nucleic Vaccine Sales Market Share in Value by Application in 2020
Table 63. Asia-Pacific Nucleic Vaccine Sales by Application (2016-2021) (K Units)
Table 64. Asia-Pacific Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 65. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Application in 2020
Table 66. Latin America Nucleic Vaccine Sales by Application (2016-2021) (K Units)
Table 67. Latin America Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 68. Latin America Nucleic Vaccine Sales Market Share in Value by Application in 2020
Table 69. Middle East and Africa Nucleic Vaccine Sales by Application (2016-2021) (K Units)
Table 70. Middle East and Africa Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 71. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Application in 2020
Table 72. North America Nucleic Vaccine Sales by Country (2016-2021) & (K Units)
Table 73. North America Nucleic Vaccine Sales Market Share in Volume by Country (2016-2021)
Table 74. North America Nucleic Vaccine Sales by Country (2016-2021) & (US$ Million)
Table 75. North America Nucleic Vaccine Sales Market Share in Value by Country (2016-2021)
Table 76. North America Nucleic Vaccine Sales by Country (2022-2027) & (K Units)
Table 77. North America Nucleic Vaccine Sales Market Share in Volume by Country (2022-2027)
Table 78. North America Nucleic Vaccine Sales by Country (2022-2027) & (US$ Million)
Table 79. North America Nucleic Vaccine Sales Market Share in Value by Country (2022-2027)
Table 80. Europe Nucleic Vaccine Sales by Country (2016-2021) & (K Units)
Table 81. Europe Nucleic Vaccine Sales Market Share in Volume by Country (2016-2021)
Table 82. Europe Nucleic Vaccine Sales by Country (2016-2021) & (US$ Million)
Table 83. Europe Nucleic Vaccine Sales Market Share in Value by Country (2016-2021)
Table 84. Europe Nucleic Vaccine Sales by Country (2022-2027) & (K Units)
Table 85. Europe Nucleic Vaccine Sales Market Share in Volume by Country (2022-2027)
Table 86. Europe Nucleic Vaccine Sales by Country (2022-2027) & (US$ Million)
Table 87. Europe Nucleic Vaccine Sales Market Share in Value by Country (2022-2027)
Table 88. Asia-Pacific Nucleic Vaccine Sales by Region (2016-2021) & (K Units)
Table 89. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Region (2016-2021)
Table 90. Asia-Pacific Nucleic Vaccine Sales by Region (2016-2021) & (US$ Million)
Table 91. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Region (2016-2021)
Table 92. Asia-Pacific Nucleic Vaccine Sales by Region (2022-2027) & (K Units)
Table 93. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Region (2022-2027)
Table 94. Asia-Pacific Nucleic Vaccine Sales by Region (2022-2027) & (US$ Million)
Table 95. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Region (2022-2027)
Table 96. Latin America Nucleic Vaccine Sales by Country (2016-2021) & (K Units)
Table 97. Latin America Nucleic Vaccine Sales Market Share in Volume by Country (2016-2021)
Table 98. Latin America Nucleic Vaccine Sales by Country (2016-2021) & (US$ Million)
Table 99. Latin America Nucleic Vaccine Sales Market Share in Value by Country (2016-2021)
Table 100. Latin America Nucleic Vaccine Sales by Country (2022-2027) & (K Units)
Table 101. Latin America Nucleic Vaccine Sales Market Share in Volume by Country (2022-2027)
Table 102. Latin America Nucleic Vaccine Sales by Country (2022-2027) & (US$ Million)
Table 103. Latin America Nucleic Vaccine Sales Market Share in Value by Country (2022-2027)
Table 104. Middle East and Africa Nucleic Vaccine Sales by Country (2016-2021) & (K Units)
Table 105. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Country (2016-2021)
Table 106. Middle East and Africa Nucleic Vaccine Sales by Country (2016-2021) & (US$ Million)
Table 107. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Country (2016-2021)
Table 108. Middle East and Africa Nucleic Vaccine Sales by Country (2022-2027) & (K Units)
Table 109. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Country (2022-2027)
Table 110. Middle East and Africa Nucleic Vaccine Sales by Country (2022-2027) & (US$ Million)
Table 111. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Country (2022-2027)
Table 112. Moderna Corporation Information
Table 113. Moderna Introduction and Business Overview
Table 114. Moderna Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Moderna Nucleic Vaccine Product
Table 116. Moderna Recent Development
Table 117. CureVac Corporation Information
Table 118. CureVac Introduction and Business Overview
Table 119. CureVac Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. CureVac Nucleic Vaccine Product
Table 121. CureVac Recent Development
Table 122. Inovio Corporation Information
Table 123. Inovio Introduction and Business Overview
Table 124. Inovio Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Inovio Nucleic Vaccine Product
Table 126. Inovio Recent Development
Table 127. Sanofi Corporation Information
Table 128. Sanofi Introduction and Business Overview
Table 129. Sanofi Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Sanofi Nucleic Vaccine Product
Table 131. Sanofi Recent Development
Table 132. GSK Corporation Information
Table 133. GSK Introduction and Business Overview
Table 134. GSK Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. GSK Nucleic Vaccine Product
Table 136. GSK Recent Development
Table 137. CNBG Corporation Information
Table 138. CNBG Introduction and Business Overview
Table 139. CNBG Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. CNBG Nucleic Vaccine Product
Table 141. CNBG Recent Development
Table 142. Hualan Bio Corporation Information
Table 143. Hualan Bio Introduction and Business Overview
Table 144. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Hualan Bio Nucleic Vaccine Product
Table 146. Hualan Bio Recent Development
Table 147. Zhifei Shengwu Corporation Information
Table 148. Zhifei Shengwu Introduction and Business Overview
Table 149. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Zhifei Shengwu Nucleic Vaccine Product
Table 151. Zhifei Shengwu Recent Development
Table 152. Liaoning Chengda Corporation Information
Table 153. Liaoning Chengda Introduction and Business Overview
Table 154. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. Liaoning Chengda Nucleic Vaccine Product
Table 156. Liaoning Chengda Recent Development
Table 157. BioKangtai Corporation Information
Table 158. BioKangtai Introduction and Business Overview
Table 159. BioKangtai Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. BioKangtai Nucleic Vaccine Product
Table 161. BioKangtai Recent Development
Table 162. CanSinoBIO Corporation Information
Table 163. CanSinoBIO Introduction and Business Overview
Table 164. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 165. CanSinoBIO Nucleic Vaccine Product
Table 166. CanSinoBIO Recent Development
Table 167. Walvax Biotechnology Corporation Information
Table 168. Walvax Biotechnology Introduction and Business Overview
Table 169. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 170. Walvax Biotechnology Nucleic Vaccine Product
Table 171. Walvax Biotechnology Recent Development
Table 172. Fosun Pharma Corporation Information
Table 173. Fosun Pharma Introduction and Business Overview
Table 174. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 175. Fosun Pharma Nucleic Vaccine Product
Table 176. Fosun Pharma Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Nucleic Vaccine Market Trends
Table 180. Nucleic Vaccine Market Drivers
Table 181. Nucleic Vaccine Market Challenges
Table 182. Nucleic Vaccine Market Restraints
Table 183. Nucleic Vaccine Distributors List
Table 184. Nucleic Vaccine Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Nucleic Vaccine Product Picture
Figure 2. Global Nucleic Vaccine Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Nucleic Vaccine Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Nucleic Vaccine Sales Status and Outlook (2016-2027) & (K Units)
Figure 5. Product Picture of Preventive Nucleic Vaccine
Figure 6. Global Preventive Nucleic Vaccine Sales YoY Growth (2016-2021) & (K Units)
Figure 7. Product Picture of Therapeutic Nucleic Vaccine
Figure 8. Global Therapeutic Nucleic Vaccine Sales YoY Growth (2016-2021) & (K Units)
Figure 9. Global Nucleic Vaccine Sales by Type (2016-2027) & (US$ Million)
Figure 10. Global Nucleic Vaccine Sales Market Share in Volume by Type (2016-2021)
Figure 11. Global Nucleic Vaccine Sales Market Share in Value by Type (2016-2021)
Figure 12. Global Nucleic Vaccine Sales Market Share in Volume by Type (2022-2027)
Figure 13. Global Nucleic Vaccine Sales Market Share in Value by Type (2022-2027)
Figure 14. North America Nucleic Vaccine Sales Market Share in Volume by Type in 2020
Figure 15. North America Nucleic Vaccine Sales Market Share in Value by Type in 2020
Figure 16. Europe Nucleic Vaccine Sales Market Share in Volume by Type in 2020
Figure 17. Europe Nucleic Vaccine Sales Market Share in Value by Type in 2020
Figure 18. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Type in 2020
Figure 19. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Type in 2020
Figure 20. Latin America Nucleic Vaccine Sales Market Share in Volume by Type in 2020
Figure 21. Latin America Nucleic Vaccine Sales Market Share in Value by Type in 2020
Figure 22. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Type in 2020
Figure 23. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Type in 2020
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Vaccine Sales in 2020
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Vaccine Revenue in 2020
Figure 26. Nucleic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 27. Product Picture of Hospital
Figure 28. Global Hospital Sales YoY Growth (2016-2027) & (K Units)
Figure 29. Product Picture of Clinic
Figure 30. Global Clinic Sales YoY Growth (2016-2027) & (K Units)
Figure 31. Product Picture of Others
Figure 32. Global Others Sales YoY Growth (2016-2027) & (K Units)
Figure 33. Global Nucleic Vaccine Sales by Application (2016-2027) & (US$ Million)
Figure 34. Global Nucleic Vaccine Sales Market Share in Volume by Application (2016-2021)
Figure 35. Global Nucleic Vaccine Sales Market Share in Value by Application (2016-2021)
Figure 36. Global Nucleic Vaccine Sales Market Share in Volume by Application (2022-2027)
Figure 37. North America Nucleic Vaccine Sales Market Share in Volume by Application in 2020
Figure 38. Latin America Nucleic Vaccine Sales Market Share in Value by Application in 2020
Figure 39. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Application in 2020
Figure 40. Key Raw Materials Price
Figure 41. Nucleic Vaccine Manufacturing Cost Structure
Figure 42. Nucleic Vaccine Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Keyplayers in Global Nucleic Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
ModernaCureVac
Inovio
Sanofi
GSK
CNBG
Hualan Bio
Zhifei Shengwu
Liaoning Chengda
BioKangtai
CanSinoBIO
Walvax Biotechnology
Fosun Pharma